Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd
SSE:603227.SS
9.7 (CNY) • At close April 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,101.2 | 7,020.927 | 6,902.516 | 2,606.085 | 2,028.588 | 2,134.695 | 2,034.284 | 1,273.441 | 928.159 | 859.077 | 909.318 | 1,059.243 | 1,064.549 | 811.748 |
| Cost of Revenue
| 4,684.933 | 5,376.821 | 4,885.44 | 2,105.499 | 1,613.946 | 1,725.24 | 1,675.69 | 972.618 | 686.405 | 600.964 | 574.895 | 684.407 | 655.267 | 488.012 |
| Gross Profit
| 1,416.267 | 1,644.106 | 2,017.076 | 500.586 | 414.642 | 409.455 | 358.594 | 300.823 | 241.754 | 258.112 | 334.423 | 374.836 | 409.282 | 323.736 |
| Gross Profit Ratio
| 0.232 | 0.234 | 0.292 | 0.192 | 0.204 | 0.192 | 0.176 | 0.236 | 0.26 | 0.3 | 0.368 | 0.354 | 0.384 | 0.399 |
| Reseach & Development Expenses
| 17.253 | 34.478 | 46.464 | 11.887 | 7.6 | 6.677 | 5.312 | 1.654 | 2.567 | 2.191 | 2.307 | 3.903 | 10.718 | 0 |
| General & Administrative Expenses
| 305.245 | 296.55 | 61.264 | 41.608 | 34.574 | 30.607 | 47.105 | 49.668 | 51.399 | 41.673 | 42.264 | 52.024 | 47.68 | 112.644 |
| Selling & Marketing Expenses
| 10.105 | 10.914 | 44.306 | 23.802 | 17.435 | 34.654 | 27.95 | 27.266 | 25.753 | 22.198 | 25.282 | 29.75 | 33.106 | 37.319 |
| SG&A
| 315.35 | 307.464 | 105.571 | 65.41 | 52.009 | 65.261 | 75.054 | 76.935 | 77.152 | 63.871 | 67.546 | 81.774 | 80.786 | 149.962 |
| Other Expenses
| 153.077 | 137.603 | 284.947 | 140.089 | 103.23 | 109.23 | -6.087 | -3.991 | 29.206 | 97.975 | 23.075 | 16.721 | 6.391 | 1.072 |
| Operating Expenses
| 485.68 | 479.545 | 436.983 | 217.386 | 162.839 | 181.167 | 167.968 | 192.472 | 189.234 | 167.166 | 170.664 | 188.43 | 182.275 | 164.026 |
| Operating Income
| 930.587 | 1,164.562 | 1,500.887 | 254.048 | 209.615 | 183.982 | 154.019 | 86.634 | -32.093 | 73.954 | 140.39 | 167.77 | 224.154 | 186.892 |
| Operating Income Ratio
| 0.153 | 0.166 | 0.217 | 0.097 | 0.103 | 0.086 | 0.076 | 0.068 | -0.035 | 0.086 | 0.154 | 0.158 | 0.211 | 0.23 |
| Total Other Income Expenses Net
| 1.208 | 1.277 | -14.949 | -10.145 | -17.212 | -7.312 | -10.189 | -3.991 | -1.263 | 94.81 | 22.219 | 10.416 | 1.868 | 1.072 |
| Income Before Tax
| 931.795 | 1,165.838 | 1,485.938 | 248.275 | 191.829 | 176.669 | 147.932 | 82.644 | -4.252 | 168.764 | 162.609 | 178.186 | 226.022 | 187.965 |
| Income Before Tax Ratio
| 0.153 | 0.166 | 0.215 | 0.095 | 0.095 | 0.083 | 0.073 | 0.065 | -0.005 | 0.196 | 0.179 | 0.168 | 0.212 | 0.232 |
| Income Tax Expense
| 176.166 | 214.576 | 228.016 | 52.747 | 52.074 | 50.615 | 48.592 | 19.647 | 3.056 | 44.514 | 32.84 | 40.448 | 44.538 | 36.072 |
| Net Income
| 668.432 | 853.532 | 1,257.922 | 195.528 | 107.493 | 95.2 | 51.775 | 18.46 | -24.868 | 94.729 | 86.772 | 95.693 | 140.18 | 124.505 |
| Net Income Ratio
| 0.11 | 0.122 | 0.182 | 0.075 | 0.053 | 0.045 | 0.025 | 0.014 | -0.027 | 0.11 | 0.095 | 0.09 | 0.132 | 0.153 |
| EPS
| 0.62 | 0.82 | 1.53 | 0.27 | 0.16 | 0.14 | 0.079 | 0.028 | -0.053 | 0.32 | 0.18 | 0.19 | 0.29 | 0.26 |
| EPS Diluted
| 0.62 | 0.82 | 1.53 | 0.27 | 0.16 | 0.14 | 0.079 | 0.028 | -0.053 | 0.32 | 0.18 | 0.19 | 0.29 | 0.26 |
| EBITDA
| 1,335.52 | 1,545.183 | 1,893.066 | 1,614.319 | 336.671 | 317.504 | 285.039 | 202.108 | 129.12 | 271.554 | 209.305 | 244.679 | 273.642 | 159.71 |
| EBITDA Ratio
| 0.219 | 0.22 | 0.274 | 0.619 | 0.166 | 0.149 | 0.14 | 0.159 | 0.139 | 0.316 | 0.23 | 0.231 | 0.257 | 0.197 |